Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Therma Bright (TBRIF)
OTHER OTC:TBRIF
Holding TBRIF?
Track your performance easily
TBRIF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range<$0.01 - $0.07
Previous Close$0.05
Volume1.13M
Average Volume (3M)392.10K
Market Cap
$16.27M
Enterprise Value$16.33M
Total Cash (Recent Filing)C$1.14K
Total Debt (Recent Filing)C$78.59K
Price to Earnings (P/E)―
Beta1.50
Next Earnings
Dec 20, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding420,615,855
10 Day Avg. Volume191,811
30 Day Avg. Volume392,104
Standard Deviation2.18
R-Squared0.03
Alpha0.28
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)1060.10
Price to Cash Flow (P/CF)841.10
P/FCF Ratio653.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Therma Bright News
PremiumCompany Announcements
Therma Bright Enhances Balance and Seeks FDA Insight
PremiumCompany Announcements
Therma Bright Inc. Strengthens Advisory Board
PremiumCompany Announcements
Therma Bright Applauds Partner’s Prestigious RDD Award
PremiumCompany Announcements
Therma Bright’s Investment Scores Big with Preva Device’s Trial Success
PremiumCompany Announcements
Therma Bright Gains U.S. Partner for Venowave Sales
PremiumCompany Announcements
Therma Bright’s Venowave VW5 Gains Medicare Code
PremiumCompany Announcements
Therma Bright’s Tech Eyed for Cough Drug Trial
PremiumCompany Announcements
Therma Bright Inc. Boosts Advisory Board with Industry VeteranOptions Prices
Currently, No data available
---
Ownership Overview
21.83% Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
78.17% Public Companies and
Individual Investors
TBRIF FAQ
What was Therma Bright’s price range in the past 12 months?
Therma Bright lowest stock price was <$0.01 and its highest was $0.07 in the past 12 months.
What is Therma Bright’s market cap?
Currently, no data Available
When is Therma Bright’s upcoming earnings report date?
Therma Bright’s upcoming earnings report date is Dec 20, 2024 which is in 91 days.
How were Therma Bright’s earnings last quarter?
Therma Bright released its earnings results on Jun 28, 2024. The company reported >-$0.001 earnings per share for the quarter, missing the consensus estimate of N/A by >-$0.001.
Is Therma Bright overvalued?
According to Wall Street analysts Therma Bright’s price is currently Overvalued.
Does Therma Bright pay dividends?
Therma Bright does not currently pay dividends.
What is Therma Bright’s EPS estimate?
Therma Bright’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Therma Bright have?
Therma Bright has 315,915,860 shares outstanding.
What happened to Therma Bright’s price movement after its last earnings report?
Therma Bright reported an EPS of >-$0.001 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Therma Bright?
Currently, no hedge funds are holding shares in TBRIF
---
Therma Bright Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Insider Transactions
Bought Shares
Worth $137.0K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
43.33%
12-Months-Change
Fundamentals
Return on Equity
-177.74%
Trailing 12-Months
Asset Growth
53.29%
Trailing 12-Months
Company Description
Therma Bright
Therma Bright, Inc. develops and markets skin care medical device products. Its products include Therapik, which is used to relieve the pain, itch and inflammation of stings and bites from different species of insects and InterceptCS, which is a device to prevent cold sore outbreaks. The company was founded on March 05, 2001 and is headquartered in Toronto, Canada.
---
Technical Analysis
---